Clinical and molecular genetics of the phosphodiesterases (PDEs)

MF Azevedo, FR Faucz, E Bimpaki, A Horvath… - Endocrine …, 2014 - academic.oup.com
Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that have the unique function of
terminating cyclic nucleotide signaling by catalyzing the hydrolysis of cAMP and GMP. They …

Guanylyl cyclase structure, function and regulation

LR Potter - Cellular signalling, 2011 - Elsevier
Nitric oxide, bicarbonate, natriuretic peptides (ANP, BNP and CNP), guanylins, uroguanylins
and guanylyl cyclase activating proteins (GCAPs) activate a family of enzymes variously …

The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment

AM Fajardo, GA Piazza, HN Tinsley - Cancers, 2014 - mdpi.com
For more than four decades, the cyclic nucleotides cyclic AMP (cAMP) and cyclic GMP
(cGMP) have been recognized as important signaling molecules within cells. Under normal …

RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma

S Chen, J Zeng, L Huang, Y Peng, Z Yan… - Journal of Translational …, 2022 - Springer
Background RNA adenosine modifications, which are primarily mediated by “writer”
enzymes (RMWs), play a key role in epigenetic regulation in various biological processes …

Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets

F Ahmad, T Murata, K Shimizu, E Degerman… - Oral …, 2015 - Wiley Online Library
By catalyzing hydrolysis of cyclic adenosine monophosphate (cAMP) and cyclic guanosine
monophosphate (cGMP), cyclic nucleotide phosphodiesterases are critical regulators of their …

Targeting cancer with phosphodiesterase inhibitors

R Savai, SS Pullamsetti, GA Banat… - Expert opinion on …, 2010 - Taylor & Francis
Importance of the field: For many cancers, there has been a shift from management with
traditional, nonspecific cytotoxic chemotherapies to treatment with molecule-specific …

Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders

SA Waldman, M Camilleri - Gut, 2018 - gut.bmj.com
Functional gastrointestinal disorders (FGIDs) and IBDs are two of the most prevalent
disorders of the GI tract and consume a significant proportion of healthcare resources …

Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics

LR Forte Jr - Pharmacology & therapeutics, 2004 - Elsevier
Guanylin, uroguanylin, and the bacterial heat-stable enterotoxin (ST) peptides comprise a
new family of cyclic guanosine 3′-5′ monophosphate (cGMP)-regulating agonists. The …

Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases

LR Potter - Pharmacology & therapeutics, 2011 - Elsevier
Cyclic GMP is a ubiquitous second messenger that regulates a wide array of physiologic
processes such as blood pressure, long bone growth, intestinal fluid secretion …

Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity

P Li, S Schulz, A Bombonati, JP Palazzo, TM Hyslop… - Gastroenterology, 2007 - Elsevier
Background & Aims: The most commonly lost gene products in colorectal carcinogenesis
include guanylin and uroguanylin, endogenous ligands for guanylyl cyclase C (GCC) …